Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,850,935 papers from all fields of science
Search
Sign In
Create Free Account
Doxorubicin-loaded EGFR-targeting Nanocells
Known as:
EGFR-targeted EnGeneIC Dream Vectors Containing Doxorubicin
, EGFR(V)-EDV-Dox
, EGFR (Vectibix Sequence)-Targeted EnGeneIC Dream Vectors Containing Doxorubicin
Expand
A nanocell formulation targeting the epidermal growth factor receptor (EGFR) using bispecific antibodies (bsAb) against EGFR and containing the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Dynamics Simulations of Adsorption of Natural Gas Mixtures in Graphene Nanocells
Drew Lemke
,
Alexander St. John
,
M. Roth
,
C. Wexler
2015
Corpus ID: 101571650
2013
2013
CORECT - Vectibix: stav registru k datu 7. 10. 2013
K. Hejduk
,
Petr Brabec
,
Z. Bortlíček
,
Daniel Klimeš
2013
Corpus ID: 79889926
Registr CORECT je neintervencni poregistreacni databaze zaměřena na sběr epidemiologických a klinických dat pacientů s diagnozou…
Expand
2012
2012
Häufigkeit und klinische Relevanz von KRAS Mutationen im metastasierten Dickdarmkarzinom
J. Neumann
2012
Corpus ID: 162045465
Seit gezeigt werden konnte, dass bei Patienten mit metastasiertem kolorektalem Karzinom (mKRK)eine Mutation im KRAS-Gen mit einem…
Expand
2011
2011
VECTIBIX® (panitumumab, Amgen) Anticorps anti-EGFR
F. Rancière
,
I. Debrix
,
F. Selle
2011
Corpus ID: 79200354
1 Le panitumumab est un anticorps monoclonal humain anti-EGFR. Il s'administre en perfusion intraveineuse et est indique en…
Expand
2011
2011
Panitumumab (Vectibix®) as 1st-line combination therapy for the treatment of WT KRAS metastatic colorectal cancer - 1st Update 2011
K. Hintringer
2011
Corpus ID: 69146976
In June 2011, the European Medicines Agency (EMA) extended the licensed indication for panitumumab (Vectibix®), a monoclonal…
Expand
Review
2011
Review
2011
[Pharmacological and clinical profiles of panitumumab injection (Vectibix®)].
T. Matsudaira
,
Daisuke Asahi
,
I. Yana
,
Masayuki Aboshi
Nihon yakurigaku zasshi. Folia pharmacologica…
2011
Corpus ID: 46267323
2010
2010
Panitumumab (Vectibix ®) for the first-line treatment of metastatic colorectal cancer
K. Hintringer
2010
Corpus ID: 56580629
Despite data indicating that patients suffering from metastatic colorectal cancer with wild-type KRAS status might benefit from…
Expand
2010
2010
Companion diagnostic development and commercialization: The good, the bad, and the ugly
D. Jackson
2010
Corpus ID: 73172751
QIAGEN (formerly DxS Ltd) has established itself as the market leader in the successful co-development of drug-diagnostic…
Expand